Boehringer Ingelheim Mexico - Press Releases
- Landmark Trial Ontarget® Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population - 30 April 2008 09:36
- Boehringer Ingelheim Outpaces the Market yet Again in 2007 - 30 April 2008 09:26
- Ablynx and Boehringer Ingelheim Announce Major Global Strategic Alliance to Discover, Develop and Commercialise Novel Nanobody® Therapeutics - 14 September 2007 15:31
- Boehringer Ingelheim Mexico – FDA Certified Third Time in a Row, With Excellent Results - 02 August 2007 16:22
- Boheringer Opens Contract Manufacturing Business In Mexico - 04 May 2007 12:36
- Boehringer Ingelheim Mexico Invites you to Interphex 2007 in New York - 01 May 2007 12:16
Copyright 2008 SPG Media Limited a subsidiary of SPG Media Group PLC
